Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (manufacturer number # IE-1577272925-201601268) on 16-FEB-2016. This case was received from the health authority on 12-Feb-2016. Ref IE-HPRA-2016-025846. Initial report was received by the RA on 28/Jan/2016 from a member of the public which concerns a 12 years (also reported as 13 years) old female patient who experienced Headache, Myalgia, Muscle spasms on 16-Apr-2015 and Pain on an unknown date following vaccination with GARDASIL on 16-Apr-2015. Concomitant medications: None. Medical history/concurrent conditions: None reported. The patient was vaccinated with her second dose of GARDASIL on 16/Apr/2015 (lot number # J011209 and J013414) and the reporter indicated that the patient has been suffering with headaches and extreme muscle pain/spasms since. The patient is in pain every day now and has been to A&E three times, admitted once and still has no relief for the pain. The reporter indicated the patient''s schooling is becoming affected and her day to day life is getting worse each day. Corrective treatment: Anti-inflammatories, pain killers and physiotherapy. At the time of reporting the patient''s symptoms were persisting. The patient is currently on a waiting list to see a specialist.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166